Bortezomib in the Treatment of Multiple Myeloma

ISBN: 978-3-7643-8947-5 (Print) 978-3-7643-8948-2 (Online)

Table of contents (11 chapters)

  1. Front Matter

    Pages i-viii

  2. No Access

    Book Chapter

    Pages 1-27

    Bortezomib’s Scientific Origins and Its Tortuous Path to the Clinic

  3. No Access

    Book Chapter

    Pages 29-42

    Preclinical Activities of Bortezomib in MM, the Bone Marrow Microenvironment and Pharmacogenomics

  4. No Access

    Book Chapter

    Pages 43-52

    Bortezomib and Osteoclasts and Osteoblasts

  5. No Access

    Book Chapter

    Pages 53-68

    Bortezomib in the Upfront Treatment of Multiple Myeloma

  6. No Access

    Book Chapter

    Pages 69-77

    The Use of Bortezomib in Autologous Transplantation for Multiple Myeloma

  7. No Access

    Book Chapter

    Pages 79-94

    Bortezomib in Relapsed and Relapsed/Refractory Multiple Myeloma

  8. No Access

    Book Chapter

    Pages 95-105

    Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma: Principles of Identification and Management

  9. No Access

    Book Chapter

    Pages 107-121

    Bortezomib in Mantle Cell Lymphoma

  10. No Access

    Book Chapter

    Pages 123-133

    Bortezomib in Waldenstrom’s Macroglobulinemia

  11. No Access

    Book Chapter

    Pages 135-148

    Bortezomib in Systemic Light-Chain Amyloidosis

  12. No Access

    Book Chapter

    Pages 149-176

    Second-Generation Proteasome Inhibitors

  13. Back Matter

    Pages 177-179